Abstract:BACKGROUND:Coxsackievirus B3 (CVB3) is a leading cause of viral myocarditis and is currently lacking specific pharmacological treatments, highlighting the critical need for therapeutic development. Icariin (ICA), a prenylated flavonol glycoside, was previously found to exhibit several pharmacological effects, but its potential to combat CVB3 remains uninvestigated. PURPOSE:This study aimed to elucidate the anti-CVB3 efficacy of ICA and elucidate its molecular mechanisms. METHODS:CVB3-infected HeLa cells, H9C2 cells and neonate rat ventricular cardiomyocytes (NRVCs) were selected as in vitro models, and were treated with ICA at 1 and 10 μM. Additionally, BALB/c mice that were infected with CVB3 via intraperitoneal injection were chosen as in vivo model and were treated with ICA or ribavirin over 3 days. The effect of ICA against CVB3 was determined by Cell Counting Kit-8 (CCK-8) assay, western blot, real-time fluorescence quantitative PCR (RT-qPCR), terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, hematoxylin and eosin (H&E) staining, immunohistochemistry (IHC) and flow cytometry. RESULTS:In this study, it was found that ICA is capable of reducing CVB3 viral load both in vitro and in vivo. Mechanistic studies suggested that ICA prevents cardiomyocyte apoptosis by attenuating the S100 calcium binding protein A6 (S100A6)/β-catenin/c-Myc signaling pathway. Additionally, ICA inhibits the secretion of proinflammatory cytokines tumor necrosis factor alpha (TNF-α), interleukin-1beta (IL-1β) and CXC motif chemokine ligand 2 (CXCL2) in heart tissue, thereby mitigating CVB3-induced myocarditis. Moreover, ICA also regulates the immune response of CD4+ T, CD8+ T and Treg cells by changing the cells numbers in spleen tissue. Lastly, ICA can reduce the load of other enteroviruses (such as CVA6, CVA16 and EV71) in rhabdomyosarcoma (RD) cells as well. CONCLUSION:Our findings indicate that ICA provides significant protection against CVB3 infection by modulating the S100A6/β-catenin/c-Myc signaling pathway, suggesting its potential use as a novel drug against CVB3 infection in clinical application.

Green Tea Polyphenol Epigallocatechin-3-gallate–Alleviated Coxsackievirus B3–induced Myocarditis Through Inhibiting Viral Replication but Not Through Inhibiting Inflammatory Responses

Ginkgo biloba extract may alleviate viral myocarditis by suppression of S100A4 and MMP-3.

Protective Effects of 20(S)-Protopanaxtriol on Viral Myocarditis Infected by Coxsackievirus B3

EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection

Coxsackievirus B3 Infection Induced Viral Myocarditis by Regulating the Expression Pattern of Chemokines in Cardiac Myocytes.

Icariin Ameliorates Coxsackievirus B3-induced Viral Myocarditis by Modulating the S100 Calcium Binding Protein A6/β-catenin/c-Myc Signaling Pathway

Green Tea Polyphenol Catechins Inhibit Coronavirus Replication and Potentiate the Adaptive Immunity and Autophagy-Dependent Protective Mechanism to Improve Acute Lung Injury in Mice

Ethyl Pyruvate Attenuated Coxsackievirus B3-induced Acute Viral Myocarditis by Suppression of HMGB1/RAGE/NF-ΚB Pathway

Epigallocatechin-3-gallate Ameliorates LPS-induced Inflammation by Inhibiting the Phosphorylation of Akt and ERK Signaling Molecules in Rat H9c2 Cells

Epoxyeicosatrienoic Acids Prevent Cardiac Dysfunction in Viral Myocarditis via Interferon Type I Signaling

Advancement of Experimental Studies on Traditional Chinese Herbs to Treat Viral Myocarditis Induced by Coxsackievirus B

Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19

Α-Galactosylceramide Protects Mice from Lethal Coxsackievirus B3 Infection and Subsequent Myocarditis.

Epoxyeicosatrienoic Acids Prevent Cardiac Dysfunction in Viral Myocarditis via IFN-I Signaling

Potential protective mechanisms of green tea polyphenol EGCG against COVID-19

A combination of Sophora flavescens alkaloids and Panax quinquefolium saponins attenuates coxsackievirus B3‑induced acute myocarditis in mice via NF‑κB signaling

Protective Effect of GYY4137 on Rat Myocardial Cells Infected by Coxsackie Virus B3

Amelioration of Influenza Virus-Induced Reactive Oxygen Species Formation by Epigallocatechin Gallate Derived from Green Tea

In Vivo and in Vitro Antiviral Activities of Calycosin-7-O-β-D-glucopyranoside against Coxsackie Virus B3

In Vivo and in Vitro Antiviral Activities of Calycosin-7-O-.BETA.-D-glucopyranoside against Coxsackie Virus B3

Effect of Prophylactically Applied CpG ODN on the Development of Myocarditis in Mice Infected with Coxsackievirus B3